Billionaire Profile
G.V. Prasad
Global Rank
#2344

Image: Public domain | via Wikimedia Commons

G.V. Prasad

CEO, Dr. Reddy's Laboratories
IN
Real-Time Net Worth
$1.6B
As of December 2025
Age
65
Source
Pharmaceuticals
Industry
healthcare
Citizenship
IN

Biography

G.V. Prasad, born in 1960, is a prominent figure in the Indian pharmaceutical industry. He is the co-chairman and managing director of Dr. Reddy's Laboratories, which he helped transform into a global generics powerhouse. Prasad's career includes co-founding Benzex Labs in 1985, later acquired by Dr. Reddy's, and leading Cheminor Drugs Ltd. as CEO and MD before its merger with Dr. Reddy's in 2001. His estimated net worth is $1.6 billion, placing him among the world's wealthiest individuals. He is recognized for his visionary approach, emphasizing innovation and ethical business practices. Prasad is also involved in various environmental and philanthropic initiatives.

Wealth Over Time

In-Depth Profile

Early Life

G.V. Prasad was born in Nellore, Andhra Pradesh, India, in 1960. He completed his schooling in Hyderabad and pursued higher education in chemical engineering. He studied at Alagappa College of Technology and later the Illinois Institute of Technology. Prasad furthered his education with an MBA from Purdue University in 1983.

Rise to Success

In 1985, Prasad co-founded Benzex Labs, a pharmaceutical enterprise. Benzex was later acquired by Dr. Reddy's Laboratories. From 1990, Prasad served as the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr. Reddy's Laboratories, and Prasad became the vice-chairman and CEO of the merged entity. Prasad is credited with transforming Dr. Reddy's Laboratories into a global generics powerhouse. He has also envisioned new business platforms like custom pharmaceuticals and specialty pharmaceuticals.

Key Business Strategies

Prasad's leadership at Dr. Reddy's has been marked by an emphasis on innovation, transparency, business ethics, and a flatter corporate structure. He has spearheaded the global expansion of the company and has focused on building strong research and development capabilities. His strategic decisions have helped Dr. Reddy's establish a significant presence in regulated markets like the United States and Europe. Prasad has also emphasized the importance of sustainability and has led the adoption of green technologies and processes within the company.

Philanthropy

G.V. Prasad is involved in philanthropic activities, supporting causes that he holds dear. He is the Chairman of Dr. Reddy's Institute of Life Sciences and has been involved with the Andhra Pradesh chapter of the Worldwide Fund for nature and the Acumen Fund, a non-profit venture focused on eliminating global poverty.

Career Milestones

1985

Co-founded Benzex Labs

Co-founded Benzex Labs, a pharmaceutical enterprise.

1990

CEO and MD of Cheminor Drugs Ltd

Served as the CEO and MD of Cheminor Drugs Ltd.

2001

Vice-Chairman and CEO of Dr. Reddy's Laboratories

Became the vice-chairman and CEO of Dr. Reddy's Laboratories after the merger with Cheminor Drugs.

2014

India's Best CEO (Large Company)

Awarded as India's Best CEO in the Large Company category by Business Today.

2015

India Business Leader of the Year

Awarded as India Business Leader of the Year by CNBC Asia.

2025

Reappointed as Co-Chairman and Managing Director

Reappointed as Co-Chairman and Managing Director of Dr. Reddy's Laboratories for a five-year term starting January 2026.

Philanthropy & Social Impact

Community Service

Dr. Reddy's Foundation

$NA

Supports community service and cultural promotion.

Business Philosophy & Leadership

Notable Quotes

""We create a lot of value for patients. If we can serve good health, it is enough for us.""

""Jugaad is not a good word in the pharmaceutical industry.""

Leadership Principles

Focus on the Big Picture

Seeing the broader strategic landscape while delegating operational details.

Importance of Quality

Prioritizing excellence and the highest quality standards, especially in pharmaceuticals.

Doing the Right Thing

Success follows when ethical practices are prioritized for all stakeholders.